Patents by Inventor Stefan Seemayer

Stefan Seemayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230383321
    Abstract: Disclosed herein is a method for the production of isopentenyl diphosphate, dimethylallyl diphosphate and/or isoprenoids derived therefrom.
    Type: Application
    Filed: May 17, 2021
    Publication date: November 30, 2023
    Inventors: Moritz Stefan POTT, Stefan SEEMAYER, Michael BREUER, Christian WILLRODT, Jens Klaus PLASSMEIER, Eva MAHLER, Bogdan TOKOVENKO
  • Publication number: 20230059334
    Abstract: The present invention is concerned with materials and methods for nucleic acid and/or protein analysis, including materials and methods for creating and/or analysing mutant libraries. The invention in particular relates to materials and methods for correlating a property of mutants of a target nucleic acid to the respective sequences of the mutants. The invention is particularly useful for analysing saturation mutagenesis libraries and the analysis of sensitivities to chemical or physical conditions, for example temperature stability and solvent stability, and for the analysis of production properties, for example yield or cellular localisation.
    Type: Application
    Filed: December 17, 2020
    Publication date: February 23, 2023
    Inventors: Stefan Seemayer, Holger Hartmann
  • Publication number: 20220259580
    Abstract: The present disclosure relates to methods for producing human milk oligosaccharide (HMO) core structures using glycosidases from family GH20 hexosaminidases. In particular, the present disclosure provides methods for producing lacto-N-triose II (LNT II) and/or lacto-N-tetraose (LNT) by reacting glucosamine-oxazoline and/or lacto-N-biose-oxazoline with lactose catalysed by an enzyme of the glycoside hydrolase family 20 (GH20) according to the classification of the Carbohydrate-Active-Enzymes (CAZy) database. Specific optimized enzymes are identified to catalyse the reactions.
    Type: Application
    Filed: December 9, 2019
    Publication date: August 18, 2022
    Inventors: Kai-Uwe Baldenius, Michael Breuer, Corinna Ruffer, Melanie Weingarten, Reinhard Zschoche, Stefan Seemayer, Bernd Nidetzky, Katharina Schmoelzer, Michael Puhl
  • Publication number: 20220220463
    Abstract: The present invention relates to variants of a beta-amylase which have an increased % residual exoamylase activity compared to the parent beta-amylase after heat treatment. The present invention also relates to methods of making the variant beta-amylase and the use of the variant beta-amylase in baking, detergents, personal care products, in the processing of textiles, in pulp and paper processing, in the production of ethanol, lignocellulosic ethanol or syrups and as viscosity breaker in oilfield and mining industries.
    Type: Application
    Filed: April 21, 2020
    Publication date: July 14, 2022
    Inventors: Hugo URBINA, Kristine W. CHANG, Tuan TRAN, Gina Ning Lee LOWE, Adrienne HUSTON DAVENPORT, Xuqiu TAN, Tong LI, Stefan JENEWEIN, Stefan SEEMAYER, Jochen KUTSCHER
  • Publication number: 20220017931
    Abstract: Described herein are methods for the production of 4-cyano benzoic acid or salts thereof from terephthalonitrile using nitrilase as catalyst. Also described herein are compositions including 4-cyano benzoic acid.
    Type: Application
    Filed: January 20, 2020
    Publication date: January 20, 2022
    Inventors: Diego Ghislieri, Christian Willrodt, Christopher Koradin, Stefan Seemayer, Doreen Schachtschabel, Kai-Uwe Baldenius, Roland Goetz
  • Publication number: 20210340518
    Abstract: Described herein are methods for the production of ammonium acrylate or salts thereof from acrylonitrile using nitrilase as a catalyst.
    Type: Application
    Filed: October 9, 2019
    Publication date: November 4, 2021
    Inventors: Diego Ghislieri, Tobias Joachim Zimmermann, Stefan Seemayer, Michael Breuer, Doreen Schactschabel
  • Patent number: 11066653
    Abstract: The present invention is directed to a producing a DNA methyltransferase in a recombinant host cell, wherein the DNA methyltransferase methylates DNA resulting in a DNA containing 5-methylcytosine within the recognition sequence GCNGC and wherein the DNA methyltransferase comprises less than (35) amino acid residues between amino acid residue (72) and amino acid residue (106) according to the numbering of SEQ ID NO: 33. Furthermore, the present invention is directed to the use of such DNA methyltransferase for the production of bacterial transformants comprising the steps of (a) introducing into a first bacterial host cell a polynucleotide comprising a polynucleotide sequence encoding the DNA methyltransferase to produce a methylated DNA and (b) transferring the methylated DNA from the first bacterial host cell into a second bacterial host cell, wherein the second bacterial host cell comprises a restriction endonuclease able to degrade the DNA but unable to degrade the methylated DNA.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: July 20, 2021
    Assignee: BASF SE
    Inventors: Max Fabian Felle, Stefan Seemayer
  • Publication number: 20210115422
    Abstract: Engineered variant polypeptides having amylase enzyme activity, compositions comprising the enzymes, and methods of making and using the enzymes. The genetically engineered amylase enzymes are useful in many different applications such as laundry detergents, dish washing detergents, and cleaning products for homes, industry, vehicle care, baking, animal feed, pulp and paper processing, starch processing, and ethanol production.
    Type: Application
    Filed: April 24, 2019
    Publication date: April 22, 2021
    Inventors: Asfia Qureshi, Adrienne Huston Davenport, Xuqiu Tan, Oliver Spangenberg, Amanda Rae Logue, Janina Berndt, Tong Li, Stefan Seemayer, Hans Wolfgang Hoeffken, Jingping Zhong
  • Publication number: 20200165581
    Abstract: The present invention is directed to a producing a DNA methyltransferase in a recombinant host cell, wherein the DNA methyltransferase methylates DNA resulting in a DNA containing 5-methylcytosine within the recognition sequence GCNGC and wherein the DNA methyltransferase comprises less than (35) amino acid residues between amino acid residue (72) and amino acid residue (106) according to the numbering of SEQ ID NO: 33. Furthermore, the present invention is directed to the use of such DNA methyltransferase for the production of bacterial transformants comprising the steps of (a) introducing into a first bacterial host cell a polynucleotide comprising a polynucleotide sequence encoding the DNA methyltransferase to produce a methylated DNA and (b) transferring the methylated DNA from the first bacterial host cell into a second bacterial host cell, wherein the second bacterial host cell comprises a restriction endonuclease able to degrade the DNA but unable to degrade the methylated DNA.
    Type: Application
    Filed: July 11, 2018
    Publication date: May 28, 2020
    Inventors: Max Fabian Felle, Stefan Seemayer